These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20443078)

  • 1. Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Vagefi PA; Hirose R
    J Gastrointest Cancer; 2010 Dec; 41(4):217-20. PubMed ID: 20443078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies: Role of sorafenib in HCC patients with compromised liver function.
    Di Maio M; Daniele B; Perrone F
    Nat Rev Clin Oncol; 2009 Sep; 6(9):505-6. PubMed ID: 19707242
    [No Abstract]   [Full Text] [Related]  

  • 3. Review article: the management of hepatocellular carcinoma.
    Cabrera R; Nelson DR
    Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation.
    Rowe IA
    Hepatology; 2010 Sep; 52(3):1171-2. PubMed ID: 20812364
    [No Abstract]   [Full Text] [Related]  

  • 5. Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib.
    Yeganeh M; Finn RS; Saab S
    Am J Transplant; 2009 Dec; 9(12):2851-4. PubMed ID: 20021481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma.
    Vitale A; Lombardi G; Ramirez Morales R; Cillo U
    Dig Liver Dis; 2012 May; 44(5):361-2. PubMed ID: 22424640
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete response for advanced liver cancer during sorafenib therapy: case report.
    Sacco R; Bargellini I; Gianluigi G; Bertini M; Bozzi E; Altomare E; Battaglia V; Romano A; Bertoni M; Capria A; Bresci G; Bartolozzi C
    BMC Gastroenterol; 2011 Jan; 11():4. PubMed ID: 21241463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection.
    Kim R; Menon N; Aucejo F
    Med Oncol; 2011 Dec; 28(4):1044-7. PubMed ID: 20635167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant therapy for hepatocellular carcinoma: is there an optimal approach?
    Almhanna K; Kalmadi S; Pelley R; Kim R
    Oncology (Williston Park); 2007 Aug; 21(9):1116-22; discussion 1122, 1124, 1127-8. PubMed ID: 17910314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: a case report.
    Wang Y; Speeg KV; Washburn WK; Halff G
    World J Gastroenterol; 2010 Nov; 16(43):5518-22. PubMed ID: 21086573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
    Hoffmann K; Glimm H; Radeleff B; Richter G; Heining C; Schenkel I; Zahlten-Hinguranage A; Schirrmacher P; Schmidt J; Büchler MW; Jaeger D; von Kalle C; Schemmer P
    BMC Cancer; 2008 Nov; 8():349. PubMed ID: 19036146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era.
    Pfiffer TE; Seehofer D; Nicolaou A; Neuhaus R; Riess H; Trappe RU
    Tumori; 2011; 97(4):436-41. PubMed ID: 21989430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study.
    Teng CL; Hwang WL; Chen YJ; Chang KH; Cheng SB
    World J Surg Oncol; 2012 Feb; 10():41. PubMed ID: 22339891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma.
    Horgan AM; Dawson LA; Swaminath A; Knox JJ
    J Gastrointest Cancer; 2012 Jun; 43(2):344-8. PubMed ID: 20683678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: sorafenib before liver transplantation?
    Braillon A
    Hepatology; 2010 Jun; 51(6):2232-3. PubMed ID: 20041410
    [No Abstract]   [Full Text] [Related]  

  • 16. Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?
    Kim DY; Han KH
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1585-6. PubMed ID: 22011294
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective internal radiation therapy of hepatocellular carcinoma: potential hepatopulmonary shunt reduction after sorafenib administration.
    Theysohn JM; Schlaak JF; Müller S; Ertle J; Schlosser TW; Bockisch A; Lauenstein TC
    J Vasc Interv Radiol; 2012 Jul; 23(7):949-52. PubMed ID: 22720895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target therapy for hepatocellular carcinoma: is sorafenib for everybody?
    Daniele B; Di Maio M
    J Clin Gastroenterol; 2009; 43(5):389-90. PubMed ID: 19564813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
    Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.
    Perboni G; Costa P; Fibbia GC; Morandini B; Scalzini A; Tagliani A; Cengarle R; Aitini E
    Oncologist; 2010; 15(2):142-5. PubMed ID: 20142333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.